Literature DB >> 18381381

Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival.

J Paredes1, A L Correia, A S Ribeiro, F Milanezi, J Cameselle-Teijeiro, F C Schmitt.   

Abstract

BACKGROUND: Changes in junctional catenin expression may compromise cadherin-mediated adhesion, increasing cell malignant properties such as invasive and metastatic abilities. Altered expression of alpha-, beta-, gamma- and p120-catenin has been reported to be associated with E-cadherin loss or decreased expression, in both breast carcinomas and breast cancer cell lines. AIMS AND METHODS: To investigate the expression and subcellular localisation of p120- and beta-catenin in a series of human invasive breast carcinomas, and correlate it with biological markers and clinicopathological parameters.
RESULTS: Both catenins frequently exhibited a reduced membranous or cytoplasmic staining pattern. These alterations were significantly correlated with lack of both E-cadherin and oestrogen receptor-alpha expression. It was possible to associate the expression of beta-catenin with histological grade, tumour size and nodal status, suggesting a relevant role for this catenin as a prognostic factor. The majority of E- and P-cadherin co-expressing tumours were related to cytoplasmic expression of p120-catenin; in this group of breast carcinomas, patient survival was poor.
CONCLUSION: Results indicate that p120-catenin cytoplasmic accumulation may play an important role in mediating the oncogenic effects derived from P-cadherin aberrant expression, including enhanced motility and invasion, particularly in tumours which maintain E-cadherin expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381381     DOI: 10.1136/jcp.2007.052704

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

Review 1.  Beyond E-cadherin: roles of other cadherin superfamily members in cancer.

Authors:  Frans van Roy
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

2.  E-cadherin plasticity in prostate cancer stem cell invasion.

Authors:  Kyung-Mi Bae; Nicole N Parker; Yao Dai; Johannes Vieweg; Dietmar W Siemann
Journal:  Am J Cancer Res       Date:  2010-10-20       Impact factor: 6.166

3.  Altered expression of p120catenin predicts poor outcome in invasive breast cancer.

Authors:  K Talvinen; J Tuikkala; M Nykänen; A Nieminen; J Anttinen; O S Nevalainen; S Hurme; T Kuopio; P Kronqvist
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-12       Impact factor: 4.553

4.  CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells.

Authors:  Sungmin Baek; Yong-Whan Lee; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Sae-Ock Oh
Journal:  Anat Cell Biol       Date:  2010-06-30

Review 5.  p120 catenin: an essential regulator of cadherin stability, adhesion-induced signaling, and cancer progression.

Authors:  Antonis Kourtidis; Siu P Ngok; Panos Z Anastasiadis
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

6.  BRCA1 and p53 regulate critical prostate cancer pathways.

Authors:  P De Luca; C P Moiola; F Zalazar; K Gardner; E S Vazquez; A De Siervi
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-05-14       Impact factor: 5.554

7.  Characterization of PAR1 and FGFR1 expression in invasive breast carcinomas: Prognostic significance.

Authors:  Marta Tiburcio; Sandra M A Costa; Maria DE Fatima Duarte; Fernando C Schmitt; Adhemar Longatto Filho
Journal:  Oncol Lett       Date:  2012-07-17       Impact factor: 2.967

Review 8.  Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena.

Authors:  Richard T Bryan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-02-05       Impact factor: 6.237

9.  Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.

Authors:  Bo Zhai; He-Xin Yan; Shu-Qin Liu; Lei Chen; Meng-Chao Wu; Hong-Yang Wang
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

10.  Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma.

Authors:  Y Idoux-Gillet; M Nassour; E Lakis; F Bonini; C Theillet; S Du Manoir; P Savagner
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.